Q&A: The Why and How of Business Action
The role of the private sector in fighting
HIV/AIDS, tuberculosis, and malaria has
been evolving rapidly over the years.
Indications are that businesses’ engagement
is poised to produce even bigger results in
the months and years ahead.
So Business Action asked a range of leaders
in thought and action to tell us how they see
business’ role, what the key components of
success are, and what it will take to achieve
the even-greater impact that is needed to
turn the corner in the fight.
All Files below are in PDF format.
CEO Perspectives
- John Anderson, CEO, Levi Strauss & Co.
- Debra Lee, Chairman & CEO, BET Networks
- Graham Mackay, CEO, SABMiller
- Gilles Pélisson, CEO, Accor
- Vimal Shah, CEO, Bidco Oil Company
- Daniel Vasella, Chairman & CEO, Novartis
- Andrew Wilty, CEO, GlaxoSmithKline
On-the-Ground Perspectives
- Peris Waithera,
HR Assistant,
Bidco Oil Refineries
- Gerishon Kariuki,
Peer Educator,
Phillips Pharmaceuticals (Power Technics)
- Tina Meng,
Administrative Manager,
Anglo American
- Eduard Gevorkyan,
Medical Advisor,
Shell
- Josephine,
Employee Living with HIV,
Unilever
- Thabo Baloyi,
Contracts Administrator and
Peer Educator, Living with HIV,
Mercedes-Benz Financial
Services South Africa (Pty) Ltd
- Iris Wang,
CSR Manager, GM China
- Mandlenkosi Ngxama,
Peer Educator,
Manufacturing,
Mercedes-Benz South Africa Pty Ltd
- Ncedo Deleki,
Peer Educator, Manufacturing, Mercedes-Benz South Africa Pty Ltd
- Karien Liebenberg,
Wellness Centre Manager,
Mercedes-Benz South Africa - Shared Services
Partner Perspectives
Thought-Leader Perspectives
- Frank Brown,
Dean, INSEAD
- Brent Chrite,
Gemelli Professor
and Associate Dean
Eller College of
Management at the
University of Arizona
- Stuart L. Hart,
Samuel C. Johnson
Chair of Sustainable
Global Enterprise and
Professor of Management at Cornell University’s Johnson School of Management